Distinct advantages for risk scoring models in patients with clonal cytopenia of undetermined significance
The data that support the findings of this study are available from the corresponding author upon reasonable request. Data S1. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Authors
- Antoine N. Saliba (ORCID: https://orcid.org/0000-0001-5134-7336)
- Cecilia Arana Yi
- Aref Al‐Kali (ORCID: https://orcid.org/0000-0002-0824-3715)
- Abhishek Avinash Mangaonkar (ORCID: https://orcid.org/0000-0003-2458-9887)
- Rong He (ORCID: https://orcid.org/0009-0001-5611-7078)
- J. Foran
- Maleeha Shah
- Hassan B. Alkhateeb (ORCID: https://orcid.org/0000-0002-3609-8404)
- Yael N. Kusne (ORCID: https://orcid.org/0000-0002-7325-8454)
- Mrinal M. Patnaik (ORCID: https://orcid.org/0000-0001-6998-662X)
- Patricia T. Greipp (ORCID: https://orcid.org/0000-0002-5536-9011)
- Talha Badar (ORCID: https://orcid.org/0000-0003-1548-918X)
- Kurt Bessonen
- Aasiya Matin
- Mehrdad Hefazi
- Yazan Jabban
- David S Viswanatha
- Dragan Jevremovic
- William J Hogan
Institutions
- Mayo Clinic (US)
- Jacksonville College (US)
- WinnMed (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- British Journal of Haematology
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1111/bjh.70398
- Primary Topic
- Blood disorders and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00